Ranked #1
Agitation and Alzheimer’s: Strategies for Managing Behavioral and Psychological Symptoms of Dementia
Agitation and Alzheimer’s: Strategies for Managing Behavioral and Psychological Symptoms of Dementia
Many people living with dementia experience behavioral symptoms alongside changes in their cognition. What can care part... Read more
8 Aug 2023
•
40mins
Ranked #2
Promises to Practice: Creating Sustainable Community Partnerships to Support Alzheimer’s Research
Promises to Practice: Creating Sustainable Community Partnerships to Support Alzheimer’s Research
Gina Green-Harris joins the podcast to discuss the importance of collaborating with communities in Alzheimer’s research.... Read more
26 Jul 2023
•
45mins
Similar Podcasts
Ranked #3
Study Shows APOE Gene Affects Hispanic Populations’ Risk of Cognitive Decline Differently to Non-Hispanic Populations
Study Shows APOE Gene Affects Hispanic Populations’ Risk of Cognitive Decline Differently to Non-Hispanic Populations
The APOE gene is recognized as a significant genetic risk factor for cognitive decline, with different alleles, like APO... Read more
12 Jul 2023
•
22mins
Ranked #4
Putting Lecanemab into Practice: A Clinician’s Perspective on the New Alzheimer’s Treatment
Putting Lecanemab into Practice: A Clinician’s Perspective on the New Alzheimer’s Treatment
On July 6, 2023, the U.S. Food and Drug Administration (FDA) granted full approval for the Alzheimer’s disease drug Leqe... Read more
7 Jul 2023
•
33mins
Ranked #5
Deciding to Donate: Barriers and Benefits of Brain Donations for Diverse Populations
Deciding to Donate: Barriers and Benefits of Brain Donations for Diverse Populations
Dr. Crystal Glover, health equity in aging researcher at Rush Alzheimer’s Disease Center, joins the podcast to discuss t... Read more
28 Jun 2023
•
36mins
Ranked #6
Lecanemab, Clinical Trials, and the Importance of Clinical Meaningfulness
Lecanemab, Clinical Trials, and the Importance of Clinical Meaningfulness
On June 9, 2023, the Food and Drug Administration’s (FDA) advisory committee unanimously voted to approve lecanemab, mov... Read more
14 Jun 2023
•
29mins
Ranked #7
Understanding the Social Determinants of Health and Disparities in Alzheimer’s Research
Understanding the Social Determinants of Health and Disparities in Alzheimer’s Research
Dr. Lisa Barnes joins the podcast to discuss her research focusing on how social determinants of health, specifically ra... Read more
1 Jun 2023
•
29mins
Ranked #8
Take Care of Your MIND: Reviewing the MIND Diet for Healthy Brain Aging
Take Care of Your MIND: Reviewing the MIND Diet for Healthy Brain Aging
To mark National Mediterranean Diet Month, Dr. Nathaniel Chin discusses a recent National Institute on Aging-funded stud... Read more
16 May 2023
•
7mins
Ranked #9
The National Strategy for Diversifying Alzheimer’s Research
The National Strategy for Diversifying Alzheimer’s Research
Dr. Sarah Biber, the program director for the National Alzheimer’s Coordinating Center (NACC), joins the podcast to disc... Read more
2 May 2023
•
19mins
Ranked #10
The Future of Neuroscience: Early-Career Researchers Named ’One to Watch’ by the Alzheimer’s Association
The Future of Neuroscience: Early-Career Researchers Named ’One to Watch’ by the Alzheimer’s Association
Recorded live from the Wisconsin ADRC’s Alzheimer’s Disease & Related Dementias Research Day, Dr. Nathaniel Chin dis... Read more
25 Apr 2023
•
34mins